VIRGINIA RETIREMENT SYSTEMS ET Al Reduces Holdings in Pediatrix Medical Group, Inc. $MD

VIRGINIA RETIREMENT SYSTEMS ET Al trimmed its stake in Pediatrix Medical Group, Inc. (NYSE:MD) by 43.3% in the 4th quarter, HoldingsChannel reports. The firm owned 38,050 shares of the company’s stock after selling 29,050 shares during the quarter. VIRGINIA RETIREMENT SYSTEMS ET Al’s holdings in Pediatrix Medical Group were worth $814,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of MD. Royal Bank of Canada lifted its position in shares of Pediatrix Medical Group by 23.8% in the 1st quarter. Royal Bank of Canada now owns 22,097 shares of the company’s stock worth $320,000 after purchasing an additional 4,247 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Pediatrix Medical Group by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 51,253 shares of the company’s stock worth $743,000 after purchasing an additional 2,251 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Pediatrix Medical Group by 4.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 268,506 shares of the company’s stock worth $3,891,000 after purchasing an additional 12,171 shares during the period. Cetera Investment Advisers purchased a new stake in shares of Pediatrix Medical Group in the 2nd quarter worth about $145,000. Finally, Quantbot Technologies LP purchased a new stake in shares of Pediatrix Medical Group in the 2nd quarter worth about $99,000. 97.71% of the stock is owned by hedge funds and other institutional investors.

Pediatrix Medical Group Trading Down 0.3%

Shares of NYSE MD opened at $22.43 on Monday. Pediatrix Medical Group, Inc. has a 1 year low of $11.84 and a 1 year high of $24.99. The stock has a market cap of $1.84 billion, a P/E ratio of 10.89 and a beta of 0.70. The firm has a 50-day moving average of $21.54 and a 200 day moving average of $21.59. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.33 and a quick ratio of 1.33.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07. The company had revenue of $476.20 million during the quarter, compared to analysts’ expectations of $465.83 million. Pediatrix Medical Group had a net margin of 9.02% and a return on equity of 19.94%. Pediatrix Medical Group’s revenue was up 3.9% on a year-over-year basis. During the same period last year, the company posted $0.33 EPS. As a group, sell-side analysts expect that Pediatrix Medical Group, Inc. will post 2.08 EPS for the current fiscal year.

Insider Transactions at Pediatrix Medical Group

In related news, Director Shirley A. Weis sold 36,028 shares of the business’s stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $23.75, for a total transaction of $855,665.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.80% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on MD shares. Mizuho set a $24.00 target price on shares of Pediatrix Medical Group in a research report on Friday, May 8th. Zacks Research cut shares of Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 23rd. Jefferies Financial Group reaffirmed a “buy” rating and issued a $27.00 target price on shares of Pediatrix Medical Group in a research report on Monday, April 20th. Deutsche Bank Aktiengesellschaft set a $19.00 price target on shares of Pediatrix Medical Group in a research report on Friday, February 20th. Finally, UBS Group lifted their price target on shares of Pediatrix Medical Group from $22.00 to $25.00 and gave the company a “neutral” rating in a research report on Tuesday, May 12th. One equities research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $22.50.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.